Contact this trialFirst, we need to learn more about you.
Cancer Imaging Agent
64Cu-LNTH-1363S for Sarcoma and Gastrointestinal Cancer
Recruiting1 awardPhase 1 & 2
Cincinnati, Ohio
This trial aims to test the safety and effectiveness of a new imaging agent called 64Cu-LNTH-1363S in patients with sarcomas or gastrointestinal cancers. The study will be done
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service